105
Views
35
CrossRef citations to date
0
Altmetric
Review

Bacterial ghosts as carrier and targeting systems

Pages 765-771 | Published online: 23 Feb 2005

Bibliography

  • WITTE A, WANNER G, BLAST U, HALFMANN G, SZOSTAK M, LUBITZ W: Endogenous transmembrane tunnel formation mediated by PhiX174 lysis protein E. 1. Bacterial (1990) 172:4109–4114.
  • ••Excellent electron micrographs of bacterialghosts.
  • WITTE A, BLAST U, HALFMANN G, SZOSTAK M, WANNER G, LUBITZ W: PhiX174 protein E mediated lysis of Escherichia coil. Biachimie (1990) 72:191–200.
  • WITTE A, WANNER G, SULZNER M, LUBITZ W: Dynamics of PhiX174 protein E-mediated lysis of Escherichia coll. Arch. Microbial (1992) 157:381–388.
  • WITTE A, BRAND E, SCHROT G, LUBITZ W: Pathway of PhiX174 protein E mediated lysis of Echerichia coll. In: Bacteria] growth and lysis. dePedro MA, Holtje J-V, Löffelhardt W (Eds.), Plenum Press, New York, (1993):277–283.
  • LUBITZ W, PUGSLEY AP: Changes in host cell phospholipid composition of PhiX174 gene Eproduct. FEMS Microbial. Lett.(1985) 30:171–175.
  • WITTE A, WANNER G, LUBITZ W, HOLTJE J-V: Effect of PhiX174 E-mediated lysis on murein composition of Escherichia coil. FEMS Microbial Lett. (1998) 164:149–157.
  • SCHON P, SCHROT G, WANNER G, LUBITZ W, WITTE A: Two-stage model for integration of the lysis protein E of PhiX174 into the cell envelope of scherichia coil. FEMS Microbial Rev (1995) 17:207–212.
  • •Model of the protein E induced membrane fusion process of Gram-negative bacteria.
  • WITTE A, SCHROT G, SCHON E LUBITZ W: Proline 21, a residue within the alpha-helical domain of PhiX174 lysis protein E, is required for its lysis function in Escherichia coil. Mal. Microbial. (1997) 26:337–346.
  • SCHULLER A, HARKNESS RE, ROTHER U, LUBITZ W: Deletion of C-terminal amino acid codons of PhiX174 gene E, Effects of its lysis inducing properties. Nucleic Acids Res. (1985) 13:4143–4153.
  • WITTE A, BRAND E, MAYRHOFER P, NARENDJA F, LUBITZ W: Dependence of PhiX174 protein E-mediated lysis on cell division activities of Echefichia coll. Arch. Microbial (1998) 170:259–268.
  • RESCH S, GRUBER K, WANNER G, SLATER S, DENNIS D, LUBITZ W: Aqueous release and purification of poly (3-hydroxybutyrate) from Escherichia coll. 1. Biotech. (1998) 65:173–182.
  • SZOSTAK MP, HENSEL A, EKO FO et al: Bacterial ghosts, non-living candidate vaccines. J. Biatechrial (1996) 44:161–170.
  • RONCHEL MC, MOLINA L, WITTE A etal.: Characterization of cell lysis in Pseudamonas putida induced upon expression of heterologous killing genes. Appl. EI7Vir017171e17t. A/licrobiol (1998) 64:4904–4911.
  • JECHLINGER W, SZOSTAK M, WITTE A, LUBITZ W: Altered temperature induction sensitivity of the lambda PR/ cI857 system for controlled gene E-expression in Echerichia coll. FEMS Microbial Lett. (1999) 173:347–352.
  • •Novel system for temperature induced gene expression.
  • JECHLINGER W, SZOSTAK M, LUBITZ W: Cold sensitive E-lysis systems. Gene (1998) 218:1–7.
  • KLEMM P: Fimbrial adhesins of Escherichiacoll. Rev Infect. Dis. (1985) 7:321–340.
  • BURROWS MR, SELLWOOD R, GIBBONS RA: Haemagglutinating and adhesive properties associated with the K99 anigen of bovine strains of Echerichia coll. 1. Gen. Microbial (1976) 96:269–275.
  • DE GRAAF FK, KLEMM P, GAASTRA W: Purification, characterization, and partial covalent structure of Escherichia coll. Infect. Immun. (1980) 33:877–883.
  • BERNKOP-SCHNORCH A, GABOR F, SZOSTAK MP, LUBITZ W: An adhesive drug delivery system based on K99-fimbriae. Eur. j Pharmaceut. Sci. (1995) 3:293–299.
  • EKO FO, MAYR UB, ATTRIDGE SR, LUBITZ W: Characterization and Immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. I Biatechrial (2000) 83:115–123.
  • STAHL PD, WILEMAN TE, DIMENT S, SHEPERD VL: Mannose-specific oligosaccharide recognition by mononuclear phagocytes. Biol. Cell (1984) 51:215.
  • TIETZE C, SCHLESINGER P, STAHL P:Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct inctracellular pools of receptor and their roles in receptor recycling. J. Cell Biol. (1982) 92:417.
  • ALVAREZ-DOMINGUEZ C, ROBERTS R, STAHL PD: Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. 1. Cell Sci. (1997) 110:731.
  • ASTARIE-DEQUEKER C, N'DIAYE EN, LECABE V, RITTIG MG, PRANDI J, MARIDONNEAU-PARINI I: The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. Ina/num (1999) 67:469.
  • SALLUSTO F, CELLA M, DANIELI C, LANZAVECCHIA A: Dentritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. I Exp. Med. (1995) 182:389.
  • LINEHAM SA, MARTINEZ-POMARES L, STAHL PD, GORDON S: Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: In situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular mic roglia and mesangial cells, but not dentritic cells. I Exp. Med. (1999) 189:1961.
  • LEW DB, SONGU ME, PONTOW SE, STAHL PD, RATTAZZI MC: A Mannose receptor mediates mannosyl-rich glycoprotein-induced mitogenesis in bovine airway smooth muscle cells. 1. Clin. Invest. (1994) 94:1855.
  • LIU ZH, STRIKER GE, STETLER SM, FUKUSHIMA P, PATEL A, STRIKER LJ: TNF-a and IL-la induce mannose receptors and apoptosis in glomerular mesangial but not endothelial cells. Am. I Physial. (1996) 270:C1595.
  • SHEPERD VL, TAMOWSKI BI, MCLAUGHLIN BJ: Isolation and characterization of a mannose receptor from human pigment epithelium. Invest. Ophthalm. Vis. Sci. (1991) 32:1779.
  • MAGNUSSON S, BERG T: Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem. ( 1989) 257:651.
  • MAGNUSSON S, FAEREVIK I, BERG T: Characterization of retroendocytosis in rat liver parenchymal cells and sinusoidal endothelial cells. Biochem. 1 (1992) 287:241.
  • UCCINI S, SIRIANNI MC, VINCENZI L et al: Kaposi's sarcoma cells express the macrophage.associated antigen manoose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. Pathal (1997) 150:929.
  • GROGER M, HOLNTHONER W MAURER D etal.: Dermal microvascular endothelial cells express the 180 kD macrophage mannose receptor in situ and in vitro. j Immune]. (2000) 165:5428–5434.
  • FORST-LADANI S, REDL H, HASLBERGER A et al.: Bacterial cell envelopes (ghosts) but not S-layers activate Human Endothelial Cells (HUVEC) through sCD14 and LBP mechanism. Vaccine (2000) 18:440-448 . 35.HENSEL A, LUBITZ W: Vaccination by aerosols, modulation of clearance mechanisms in the lung. Behring Inst. Mitt. (1997) 98:212–219.
  • HENSEL A, VAN LEENGOED LAG, SZOSTAK M et al: Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model. ..J. Biatechrial (1996) 44:171–181.
  • KATINGER AW, LUBITZ MP, SZOSTAK M etal.: Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actiriabacillus pleuroprieumaniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. I Biotech. (1999) 73:251–260.
  • HASELBERGER AG, MADER HJ, SCHMALNAUER M et al: Bacterial cell envelopes (ghosts) and LPS but not bacterial S-layers induce synthesis of immune-mediators in mouse macrophages involving CD14. j Eridatax. Res. (1997) 4:431–441.
  • HASLBERGER A, KOHL G, FELNEROVA D, MAYR UB, FORST-LADANI S, LUBITZ W: Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. I Biatechrial. (2000) 83:57–66.
  • MADER HJ, SZOSTAK MR HENSEL A, LUBITZ W, HASLBERGER AG: Endotoxicity does not limit the use of bacterial ghosts as candidate vaccine. Vaccine (1997) 15:195–202.
  • SZOSTAK M, LUBITZ W: Recombinant bacterial ghosts as multivaccine vehicles. In: Modern approaches to new vaccines including prevention of AIDS, Vaccines 91. Chanock RM etal. (Eds.) Cold Spring Harbor Laboratory Press, New York (1990:409–414.
  • HUTER V, SZOSTAK MP, GAMPFER J et al.: Bacterial ghosts as drug carrier and targeting vehicles. j Contrail Release (1999) 61:51–63.
  • ••First report of fffiing bacterial ghosts.
  • SLEYTR UB, BEVERIDGE TJ: BacterialS-Layers. Trends Microbial. (1999) 7:253–260.
  • KUEN B, SLEYTR UB, LUBITZ W:. Sequence analysis of the sbsA gene encoding the 130-kDa surface-layer protein of Bacillus stearothermaphilus PV72. Gene (1994) 145:115–120.
  • KUEN B, SARA M, LUBITZ W: Heterologous expression and self-assembly of the S-layer protein SbsA of Bacillus stearothermophilus in Escherichia coli. Mal Microbial (1995) 19:495–503.
  • ••First report of heterologous S-layerexpression and S-layer sheet formation in the cytoplasm of bacteria.
  • KUEN B, KOCH A, ASENBAUER W, SARA M, LUBITZ W: Molecular Characterization of the Bacillus stearothermaphilusPV72 S-Layer Gene sbsB induced by oxidative Stress. j Bacterial (1997) 179: 1664-1670.
  • TRUPPE M, HOWORKA S, SCHROLL G et al: Biotechnological applications of recombinant S-layer proteins rSbsA and rSbsB from Bacillus stearothermaphilus PV72. In: Molecular biology of S-layers. Bahl H et al. (Eds.). FEMS Microbial. Rev (1997) 20:47–98.
  • SCHATZLEIN AG, UCHEGBU IF: Non-viral vectors in gene delivery. Drug Deliv. Systems & Sci (2001) 1:17–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.